Bone metastasis in non-small-cell lung cancer: genomic characterization and exploration of potential targets
Background: Bone metastasis (BM) seriously affects the quality of life and reduces the survival time of patients with non-small-cell lung cancer (NSCLC). The genomic characteristics and potential targets of BMs are yet to be fully explored. Objective: To explore the genetic characteristics and poten...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2024-03-01
|
| Series: | Therapeutic Advances in Medical Oncology |
| Online Access: | https://doi.org/10.1177/17588359241239293 |
| _version_ | 1797255718945947648 |
|---|---|
| author | Jiali Gong Shumin Hu Qianyun Shan Jing Qin Na Han Fajun Xie Hongyang Lu |
| author_facet | Jiali Gong Shumin Hu Qianyun Shan Jing Qin Na Han Fajun Xie Hongyang Lu |
| author_sort | Jiali Gong |
| collection | DOAJ |
| description | Background: Bone metastasis (BM) seriously affects the quality of life and reduces the survival time of patients with non-small-cell lung cancer (NSCLC). The genomic characteristics and potential targets of BMs are yet to be fully explored. Objective: To explore the genetic characteristics and potential targets of BM in NSCLC. Design: In all, 83 patients with NSCLC were retrospectively selected in this study. Genomic characterization of BMs was explored with the analysis of NGS results from primary tumors and BMs in 6 patients, then combined with NGS results of lung tumors in 16 patients with initial recurrence in bone to analyze mutations potentially associated with BMs, and finally, the correlation was further validated in 61 postoperative patients. Methods: The next generation sequencing (NGS) was performed to identify genomic differences between pulmonary primary tumors and BM. Fluorescence in situ hybridization and immunohistochemistry were performed in postoperative tumor tissues from patients who had undergone radical surgery to validate the predictive role of molecular targets for BM. The correlation between cyclin-dependent kinase 4 ( CDK4 ) and BM was evaluated by Pearson’s chi-square test. The university of alabama at birminghan cancer data analysis portal (UALCAN) was carried out for the detection of CDK4 expression in lung cancer and the relationship between CDK4 and clinicopathological parameters. The relationship between prognosis and CDK4 expression was analyzed by the Kaplan–Meier plotter. Results: The rate of gene amplification was increased (24% versus 36%) while gene substitution/indel was decreased (64% versus 52%) in BMs. The BM-specific mutations were analyzed in 16 recurrent patients which revealed the highest incidence of CDK4 amplification (18.8%). According to the Kaplan–Meier plotter database, the NSCLC patients with high CDK4 gene expression showed poor overall survival (OS) and recurrence-free survival (RFS) ( p < 0.05). The incidence of CDK4 amplification tended to be higher in recurrent patients compared to the patients without BM (18.8% versus 4.7%, p = 0.118). Conclusion: Compared to the primary tumors of NSCLC, the genome of BMs showed an increased proportion of amplification and a decreased proportion of gene substitution/indel. Furthermore, the CDK4 amplification ratio seemed to be elevated in NSCLC patients with BM which may be associated with poor OS and RFS. |
| first_indexed | 2024-04-24T22:10:19Z |
| format | Article |
| id | doaj.art-52c927a84b034778a46373bbbc32ac4a |
| institution | Directory Open Access Journal |
| issn | 1758-8359 |
| language | English |
| last_indexed | 2024-04-24T22:10:19Z |
| publishDate | 2024-03-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | Therapeutic Advances in Medical Oncology |
| spelling | doaj.art-52c927a84b034778a46373bbbc32ac4a2024-03-20T09:04:24ZengSAGE PublishingTherapeutic Advances in Medical Oncology1758-83592024-03-011610.1177/17588359241239293Bone metastasis in non-small-cell lung cancer: genomic characterization and exploration of potential targetsJiali GongShumin HuQianyun ShanJing QinNa HanFajun XieHongyang LuBackground: Bone metastasis (BM) seriously affects the quality of life and reduces the survival time of patients with non-small-cell lung cancer (NSCLC). The genomic characteristics and potential targets of BMs are yet to be fully explored. Objective: To explore the genetic characteristics and potential targets of BM in NSCLC. Design: In all, 83 patients with NSCLC were retrospectively selected in this study. Genomic characterization of BMs was explored with the analysis of NGS results from primary tumors and BMs in 6 patients, then combined with NGS results of lung tumors in 16 patients with initial recurrence in bone to analyze mutations potentially associated with BMs, and finally, the correlation was further validated in 61 postoperative patients. Methods: The next generation sequencing (NGS) was performed to identify genomic differences between pulmonary primary tumors and BM. Fluorescence in situ hybridization and immunohistochemistry were performed in postoperative tumor tissues from patients who had undergone radical surgery to validate the predictive role of molecular targets for BM. The correlation between cyclin-dependent kinase 4 ( CDK4 ) and BM was evaluated by Pearson’s chi-square test. The university of alabama at birminghan cancer data analysis portal (UALCAN) was carried out for the detection of CDK4 expression in lung cancer and the relationship between CDK4 and clinicopathological parameters. The relationship between prognosis and CDK4 expression was analyzed by the Kaplan–Meier plotter. Results: The rate of gene amplification was increased (24% versus 36%) while gene substitution/indel was decreased (64% versus 52%) in BMs. The BM-specific mutations were analyzed in 16 recurrent patients which revealed the highest incidence of CDK4 amplification (18.8%). According to the Kaplan–Meier plotter database, the NSCLC patients with high CDK4 gene expression showed poor overall survival (OS) and recurrence-free survival (RFS) ( p < 0.05). The incidence of CDK4 amplification tended to be higher in recurrent patients compared to the patients without BM (18.8% versus 4.7%, p = 0.118). Conclusion: Compared to the primary tumors of NSCLC, the genome of BMs showed an increased proportion of amplification and a decreased proportion of gene substitution/indel. Furthermore, the CDK4 amplification ratio seemed to be elevated in NSCLC patients with BM which may be associated with poor OS and RFS.https://doi.org/10.1177/17588359241239293 |
| spellingShingle | Jiali Gong Shumin Hu Qianyun Shan Jing Qin Na Han Fajun Xie Hongyang Lu Bone metastasis in non-small-cell lung cancer: genomic characterization and exploration of potential targets Therapeutic Advances in Medical Oncology |
| title | Bone metastasis in non-small-cell lung cancer: genomic characterization and exploration of potential targets |
| title_full | Bone metastasis in non-small-cell lung cancer: genomic characterization and exploration of potential targets |
| title_fullStr | Bone metastasis in non-small-cell lung cancer: genomic characterization and exploration of potential targets |
| title_full_unstemmed | Bone metastasis in non-small-cell lung cancer: genomic characterization and exploration of potential targets |
| title_short | Bone metastasis in non-small-cell lung cancer: genomic characterization and exploration of potential targets |
| title_sort | bone metastasis in non small cell lung cancer genomic characterization and exploration of potential targets |
| url | https://doi.org/10.1177/17588359241239293 |
| work_keys_str_mv | AT jialigong bonemetastasisinnonsmallcelllungcancergenomiccharacterizationandexplorationofpotentialtargets AT shuminhu bonemetastasisinnonsmallcelllungcancergenomiccharacterizationandexplorationofpotentialtargets AT qianyunshan bonemetastasisinnonsmallcelllungcancergenomiccharacterizationandexplorationofpotentialtargets AT jingqin bonemetastasisinnonsmallcelllungcancergenomiccharacterizationandexplorationofpotentialtargets AT nahan bonemetastasisinnonsmallcelllungcancergenomiccharacterizationandexplorationofpotentialtargets AT fajunxie bonemetastasisinnonsmallcelllungcancergenomiccharacterizationandexplorationofpotentialtargets AT hongyanglu bonemetastasisinnonsmallcelllungcancergenomiccharacterizationandexplorationofpotentialtargets |